Abstract

Not all patents are created equal. Actually, if you were to ask someone in the generic drug business, you’d likely get an earful about patents owned by brand-name pharmaceutical companies that are weak, questionable or shouldn’t have been granted in the first place. “In the pharmaceutical

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call